AG
BIOA

Algert Global’s BioAge Labs BIOA Stock Holding History

Algert Global’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
64,226
-131,822
-67% -$2.54M 0.02% 841
2025
Q4 		$2.59M Buy
196,048
+184,896
+1,658% +$1.64M 0.04% 642
2025
Q3 		$66K Hold
11,152
– – ﹤0.01% 1105
2025
Q2 		$46K Buy
+11,152
New +$44.9K ﹤0.01% 1162

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Algert Global's BIOA Position: Q1 2026 in Review

Algert Global reduced its BioAge Labs (BIOA) stake by 67% in Q1 2026, selling an estimated $2.54M and leaving 64,226 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #841.

Algert Global first reported a position in BIOA in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.59M in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Algert Global held 64,226 shares of BioAge Labs worth $1.12M as of Q1 2026.
  • Algert Global sold 131,822 BioAge Labs shares in Q1 2026, an estimated $2.54M.
  • BioAge Labs made up 0.02% of Algert Global's portfolio in Q1 2026, its #841 holding.
  • Algert Global first reported a position in BioAge Labs in Q2 2025 and has held it in 4 quarters since.
  • Algert Global's BioAge Labs position peaked at $2.59M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.